tiprankstipranks
Trending News
More News >

Joshua Kazam Insider Profile

11 Followers
Joshua Kazam, Director at Kite Pharma Inc, holds 0.00 shares in Kronos Bio (Ticker: KRON), holds 303.06K shares in Allogene Therapeutics (Ticker: ALLO), holds 30.00K shares in Latch (Ticker: LTCH).
tipranks
Joshua Kazam

Joshua Kazam
Kite Pharma Inc (KITE)
Director

Ranked #94,577 out of 103,104 Corporate Insiders

Profitable Transactions

0%
0 out of 4 Profitable Transactions

Average Return

-49.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$15M
94.08%
3.08%
2.27%
0.54%
0.03% Others
A breakdown of Joshua Kazam's holdings

Insider Roles

TG Therapeutics
(TGTX)
Director
Capricor Therapeutics
(CAPR)
Director
Allogene Therapeutics
(ALLO)
Director
Target Hospitality
(TH)
Director
+2 other positions
Roles that Joshua Kazam holds in companies

Most Profitable Insider Trade

Stock:
Capricor Therapeutics
(CAPR)
Rating:Informative Buy
Date:Jan 22, 2015 - Jan 22, 2016
Return:-42.30%
The most profitable trade made by Joshua Kazam

Joshua Kazam's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
KITE
Kite Pharma Inc
Oct 05, 2017
Uninformative Sell
13.07M
$78.66M
Allogene Therapeutics
Jun 17, 2022
Director
Uninformative Buy
$333.37K
EAGLU
Double Eagle Acquisition Corp
Target Hospitality
Mar 05, 2019
Director
Informative Buy
51.00K
$80.00K
DraftKings
Director
KRON
Kronos Bio
Jun 20, 2025
Uninformative Sell
53.85K
$0.00
Latch
Jun 07, 2021
Former Director
Uninformative Buy
324.90K
$3.90K
Capricor Therapeutics
Jan 22, 2015
Director
Informative Buy
24.98K
$453.56K
TG Therapeutics
Director
$13.84M
List of latest transactions for each holding click on a transaction to see Joshua Kazam's performance on stock

Joshua Kazam insider profile FAQ

What is the percentage of profitable transactions made by Joshua Kazam?
The percentage of profitable transactions made by Joshua Kazam is 0%.
    What is the average return per transaction made by Joshua Kazam?
    The average return per transaction made by Joshua Kazam is -49.90%.
      What stocks does Joshua Kazam hold?
      Joshua Kazam holds: KITE, ALLO, EAGLU, TH, DKNG, KRON, LTCH, CAPR, TGTX stocks.
        What was Joshua Kazam’s latest transaction?
        Joshua Kazam latest transaction was an Uninformative Sell of $53.85K.
          What was Joshua Kazam's most profitable transaction?
          Joshua Kazam’s most profitable transaction was an Informative Buy of CAPR stock on January 22, 2015. The return on the trade was -42.30%.
            What is Joshua Kazam's role in Kite Pharma Inc?
            Joshua Kazam's role in Kite Pharma Inc is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.